None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants who are healthy with no major diseases 2. Age 18-27 years 3. Either sex or transgender 4. History of being immunized against tetanus 5. Providing written informed consent voluntarily to participate
Exclusion criteria
Exclusion criteria: 1. Subjects with untreated or active malignancy or recovered from malignancy. 2. Vulnerable populations ? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 3. Self-reported immune compromised states. 4. Diagnosed unstable psychiatric illness or other uncontrolled or life-threatening illness affecting the quality of life or any organ failure. 5. Substance abuse and/or dependence. 6. Any blood-related disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to complete resolution of pain and tenderness at the puncture siteTimepoint: Initially twice at 6 hours intervals on day 0 (immediately after the puncture, and 6 hours after the puncture), and subsequently once on day 1, day 2, day 3, and day 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| 0-100 mm visual analogue scales (VAS) measuring the intensity of puncture site pain and tenderness in both groups, measured for up to 5 days.Timepoint: Initially twice at 6 hours intervals on day 0 (immediately after the puncture, and 6 hours after the puncture), and subsequently once on day 1, day 2, day 3, and day 4 | — |
Countries
India
Contacts
D N De Homoeopathic Medical College and Hospital